close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioLife Solutions, Inc. - Common Stock (NQ:BLFS)

33.22 +0.70 (+2.14%)
Streaming Delayed Price Updated: 11:11 AM EDT, Aug 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioLife Solutions, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Halper Sadeh LLC is Investigating Whether UTZ, BLFS, FNWD, PSNL are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether UTZ, BLFS, NRIM are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether UTZ, BLFS, NG are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS
From Kahn Swick & Foti, LLC
Via Business Wire
BioLife Solutions Inc (NASDAQ:BLFS) Q1 2026 Earnings Beat Signals Profitability Milestone ↗
Via Chartmill
Topics Earnings
BioLife Solutions Inc (NASDAQ:BLFS) Surpasses Q4 2025 Estimates with Surprise Profit, Stock Rises ↗
Via Chartmill
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 7, 2025 ↗
 
Via Benzinga
News headline image
BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
BioLife (BLFS) Q1 2026 Earnings Transcript ↗
BioLife (BLFS) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Relay Therapeutics Stock Up 235% This Past Year as One Fund Lifts Bet to $110 Million ↗
Relay Therapeutics develops precision medicines targeting oncology and genetic diseases, leveraging proprietary computational technology. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
Exploring BioLife Solns's Earnings Expectations ↗
 
Via Benzinga
News headline image
Analyst Expectations For BioLife Solns's Future ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2024 ↗
 
Via Benzinga
News headline image
Key Takeaways From BioLife Solns Analyst Ratings ↗
 
Via Benzinga
News headline image
Structure Therapeutics Stock Surges 200% This Past Year as One Fund Cuts Stake by $15.5 Million ↗
This clinical-stage biotech develops oral therapies for chronic diseases, with a lead candidate targeting type-2 diabetes and obesity. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
BioLife (BLFS) Q4 2025 Earnings Call Transcript ↗
BioLife (BLFS) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
BioLife Solutions' CFO Sells 30,000 Shares ↗
This bioproduction tools provider for cell and gene therapy reported a notable insider sale. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Recap: BioLife Solns Q4 Earnings ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 29, 2024 ↗
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
News headline image
Earnings Preview For BioLife Solns ↗
 
Via Benzinga
News headline image
BioLife Solns: Q3 Earnings Insights ↗
 
Via Benzinga
News headline image
BioLife (BLFS) Q3 2025 Earnings Call Transcript ↗
BioLife (BLFS) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
BioLife Solutions Inc (NASDAQ:BLFS) Beats Q3 2025 Earnings and Revenue Estimates ↗
BioLife Solutions Q3 2025 earnings beat estimates with a surprise profit and strong revenue growth, driving a positive market response. 
Via Chartmill
Topics Earnings
News headline image
BioLife Solutions Inc (NASDAQ:BLFS) Reports Mixed Q2 2025 Results with Revenue Beat but Profitability Concerns ↗
BioLife Solutions reports Q2 2025 revenue beat but faces profitability challenges, with mixed market reaction. Cell processing growth up 28% YoY. 
Via Chartmill
News headline image
Earnings Scheduled For March 3, 2025 ↗
 
Via Benzinga
News headline image
BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q2 2024 ↗
BLFS stock results show that BioLife Solns beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q1 2024 ↗
BLFS stock results show that BioLife Solns beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Meta Platforms, Pure Storage And 2 Other Stocks Insiders Are Selling ↗
 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.